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ORIGINAL ARTICLE
Background/Aims: Underlying cardiac pathology and atrial fibrillation (AF) affect the molecular remodeling of ion
channels in the atria. Changes in the expression of these molecules have not been demonstrated in Korean
patients with mitral valvular heart disease. Thus, the purpose of this study was to analyze ion channel expression
in patients with chronic AF and mitral valvular heart disease.
Methods: A total of 17 patients (eight males and nine females; mean age, 57 ± 14 years [range, 19 to 77])
undergoing open-heart surgery were included in the study. Twelve patients (seven with coronary artery disease
and five with aortic valvular disease) had sinus rhythm, and five patients (all with mitral valvular disease) had
chronic, permanent AF. A piece of right atrial appendage tissue (0.5 g) was obtained during surgery. RT-PCR
was used to evaluate the expression of L-type Ca2+ channels, ryanodine receptor (RyR2), sarcoplasmic reticular
Ca2+-ATPase (SERCA2), gene encoding the rapid component of the delayed rectifier Ikr (HERG), gene encoding
calcium-independent transient outward current Ito1 (Kv4.3), gene encoding the ultrarapid component of the
delayed rectifier Iku (Kv1.5), K
+ channel-interacting protein 2 (KChIP2), hyperpolarization-activated cation channel
2 associated with the pacemaker current If (HCN2), and gene encoding Na
+ channel (SCN5A).  
Results: Reduced L-type Ca2+ channel, RyR2, SERCA2, Kv1.5, and KChIP2 expression and borderline
increased HCN2 expression were observed in the patients with AF and mitral valvular heart disease. Left atrial
diameter was negatively correlated with RyR2 and KChIP2 expression. Fractional area shortening of the left
atrium was positively correlated with RyR2 and KChIP2 expression. 
Conclusions: Alterations in ion channel expression and the anatomical substrate may favor the initiation and
maintenance of AF in patients with mitral valvular heart disease. (Korean J Intern Med 2010;25:377-385)
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INTRODUCTION
Atrial fibrillation (AF) begets AF; that is, AF itself alters
atrial electrophysiological properties in a manner that
favors the induction and maintenance of AF (i.e., electrical
remodeling) [1]. The major mechanisms of electrical
remodeling are initiated by an increased atrial rate.
The roughly 10-fold atrial rate increase caused by AF
substantially increases cellular Ca2+ loading by Ca2+
intake through ICa [2]. Progressive Ca2+ loading threatens
cell viability, and cells respond to minimize the impactof
the increased rate on the intracellular Ca2+ load. Thus,
defense mechanisms include voltage-dependent and
intracellular Ca2+ concentration-dependent ICa inactivation.
Decreases in ICa reduce Ca2+ entry and help to prevent Ca2+
overload; however, because ICa is a key contributor to the
action potential plateau, reductions in ICa decrease the
action potential duration (APD), reduce the refractoryperiod, and promote the induction and maintenance of AF
by multiple-circuit reentry [3]. Changes in a number of
ionic currents have been detected in persistent and
permanent human AF. An increased IK1 [4], lack of
change in INa [5], decreased Ito [4], and decreased ICa [5,6]
have been reported. Corresponding changes in IKur (no
change [5], decreased [4]), IKr, IKs, and If are not well
established [7]. 
Changes in the gene or protein expression of the
channels responsible for action potential generation have
been reported in AF. Changes in the expression of
molecules such as gene encoding calcium-independent
transient outward current Ito1 (Kv4.3) [8], α1c (ICa) [9],
gene encoding the ultrarapid component of the delayed
rectifier IKu (Kv1.5) [4], gene encoding the rapid
component of the delayed rectifier Ikr (HERG) [8], and
hyperpolarization-activated cation channel 2 associated
with the pacemaker current If (HCN) [10] have also been
reported. Molecules related to Ca
2+ homeostasis in
cardiomyocytes include ryanodine receptor (RyR2),
sarcoplasmic reticular Ca
2+-ATPase (SERCA2), phospho-
lamban, calsequestrin, and L-type Ca
2+ channels.
Decreased SERCA2 and L-type Ca
2+ channel expression
has been reported in AF, and the expression of other
molecules may be unaltered [9]. 
The assembly of four voltage-gated K+ channel Kv α-
subunits into a tetrameric structure creates a functional Ito
channel. Reduced Ito levels have been reported in various
conditions, including heart failure [11] and myocardial
infarction [12] as well as AF, and the magnitude of Ito may
affect APD [13]. Kv4.3 is responsible for most of the Ito
current in the human atrium. Assembly of theβ-subunits
into pore-forming tetramers is sufficient to generate
functional K+ channels. Kv expression is modulated by
cytoplasmic proteins such as β-subunits, K+ channel-
interacting protein (KChIP) 2, frequenin, and K+ channel-
associated protein (KChAP). KChIP was recently shown to
associate with Kv4 [14]. Of the three KChIP types known
(KChIP1, KChIP2, and KChIP3), KChIP2 is expressed in
the human heart. KChIP2 may be a regulatory subunit of
Kv4.3 [15]. 
Expression changes in these molecules have not been
demonstrated in Korean patients with mitral valvular
heart disease. Therefore, the purpose of this study was to
analyze the expression status of these molecules in patients
with chronic AF and mitral valvular heart disease.
METHODS
Patients and atrial tissue collection
A total of 17 patients (eight males and nine females;
mean age, 57 ± 14 years [range, 19 to 77]) undergoing
open heart surgery for coronary artery bypass, valve
repair, or replacement were included in the study. Twelve
patients had sinus rhythm (SR): coronary artery disease
(n = 7, CAD-SR) and aortic stenosis/stenoinsufficiency (n
= 5, AVD-SR). Five patients had permanent AF (longer
than 6 months) and mitral stenosis (MVD-AF). Written
informed consent was obtained from each patient before
all procedures. Echocardiography was performed
within 1 week, and cardiac catheterization was performed
within 1 month prior to surgery. The clinical charact-
eristics of each group are listed in Table 1. A piece of right
atrial appendage tissue (0.5 g) was obtained during
surgery. The excised samples were immediately frozen in
liquid nitrogen and stored at -80 ˚C until use.
Transthoracic echocardiography
A 2.5-MHz phased array transducer and standard
echocardiographic system (Acuson Sequoia C256,
Siemens, Washington, DC, USA)were used to measure
cardiac structural and functional parameters. Three
diameters within the left atrium (LA) were measured:
height in the parasternal long-axis view (LA1), width in the
tilted parasternal short-axis view (LA2), and height in the
apical four-chamber view (LA3). The left atrial volume was
calculated as ( × LA1 × LA2 × LA3)/8. The apical four-
chamber view was obtained and recorded on videotape for
subsequent off-line measurements. For the LA and right
atrium (RA), the largest atrial area (AAmax) during
ventricular systole and smallest area (AAmin) during
ventricular diastole were measured. Atrial fractional area
shortening (FAS) was calculated as (AAmax -
AAmin)/AAmax ×100. In the AF group, the average of three
consecutive cardiac cycles was used for each echocar-
diographic measurement. Pulmonary artery systolic
pressure (PASP) was estimated from the trans-tricuspid
pressure gradient by Doppler examination.
Cardiac catheterization
All cardiac catheterization procedures were performed
as a preoperative evaluation. In cases of rheumatic
valvular heart disease, right and left heart catheterization
was performed to obtain hemodynamic profiles of each
chamber and cardiac function. In cases of coronary artery
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coronary angiography. Pressure profiles were measured
using a standard fluid-filled catheter manometer.
Semiquantitative RT-PCR
Total RNA was extracted from the harvested atrial
tissues using the following procedure. Briefly, the frozen
tissues were homogenized with Ultraspec-II (Biotecx,
Houston, TX, USA), and the supernatant was collected
from the mixture with chloroform by centrifugation. RNA
was extracted using isopropanol, RNA Tack Resin
(Biotecx), and ethanol precipitation. First-strand cDNA
was synthesized from the RNA using the PolyATract
cDNA Synthesis System (Promega, Madison, WI, USA).
The sequences and sizes of the sense and antisense
primers used for each molecule are listed in Table 2.
cDNA amplification was performed in a thermal cycler
(GeneAmp PCR System 9600, Perkin-Elmer Cetus,
Waltham, MA, USA) using Taq polymerase (Promega).
Following denaturation at 94˚C for 5 minutes, the
samples were subjected to 30 cycles of denaturation at
94˚C for 30 seconds, annealing (see Table 2 for the
temperature) for 30 seconds, and extension at 72˚C for 7
minutes. The amplified products were electrophoresed in
1.5% agarose gels containing ethidium bromide and
examined under a UV transilluminator. The intensity of
each band was quantified using image analysis software
(TINA version 2.10, Raytest, Straubenhardt, Germany),
and the expression levels were calculated by
normalization against the intensity of β-actin. 
Statistical analysis
All numerical values are expressed as the mean ±
standard deviation. Statistical significance was determined
using the Mann-Whitney U test for group-to-group mean
comparisons. A p value of less than 0.05 was considered
to be significant. 
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Table 1. Clinical, echocardiographic, and hemodynamic parameters
Parameter SR (n = 12) AF (n = 5) p value
Age, yr 55 ± 16 61 ± 6 0.561
Male / Female 7 : 5 1 : 4 0.021
Hypertension, %  58  40  0.620
Underlying heart disease 5 : 7 5 : 0 0.008
(rheumatic : non-rheumatic)
SBP, mmHg 156 ± 29 134 ± 30 0.349
DBP, mmHg 76 ± 12 79 ± 14 0.660
LA diameter, mm 44 ±  6 65 ± 7 0.002
LA volume, mL 35 ± 13 121 ± 63 0.004
AAmax of LA, cm2 19 ± 5 42 ± 20 0.009
AAmin of LA, cm2 11 ± 5 34 ± 19 0.004
FAS of LA , % 46 ± 15 19 ± 13 0.009
AAmax of RA, cm2 16 ± 4 25 ± 8 0.039
AAmini of RA, cm2 8 ± 2 20 ± 6 0.003
FAS of RA, % 48 ± 14 19 ± 7 0.009
LVESD, mm 36 ± 9 41 ± 6 0.187
LVEDD, mm 53 ± 10 58 ± 9 0.395
LVEF, % 53 ± 7 49 ± 6 0.246
PASP, mmHg 33 ± 5 54 ± 9 0.003
Mean RAP, mmHg 5 ± 3 7 ± 4 0.643
LAP, mmHg 17 ± 10 28 ± 14 0.280
LVEDP, mmHg 18 ± 9 11 ± 5 0.161
Values are presented as mean ± SD.
SR, sinus rhythm; AF, atrial fibrillation; SBP, systolic blood pressure; DBP, diastolic blood pressure; LA, left atrium; RA, right atrium;
AA, atrial area measured in the apical four-chamber view; FAS, fractional area shortening; LVESD, left ventricular end-systolic
diameter; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; PASP, pulmonary artery systolic
pressure; RAP, right atrial pressure; LAP, left atrial pressure; LVEDP, left ventricular end-diastolic pressure.RESULTS
Clinical parameters of the enrolled patients
Parameters such as sex, underlying heart disease, atrial
diameter, left atrial volume, and PASP were significantly
different between the SR and AF groups (Table 1). Briefly,
more female patients, more patients with rheumatic
valvular heart disease, a larger atrium, lower FAS of the
LA, and higher PASP were common among the patients in
the AF group.
Molecules related to Ca2+ homeostasis
Reduced L-type Ca2+ channel, RyR2, and SERCA2
expression was observed in the AF group (Fig. 1). Atrial
samples obtained from patients in the MVD-AF group
showed reduced RyR2 expression compared with the
AVD-SR group; however, no significant difference in L-
type Ca2+ channel and SERCA2 expression was noted
between the AVD-SR and MVD-AF groups (Table 3). A
significant reduction in SERCA2 expression and borderline
significance in the differences in the expression of L-type
Ca2+ channels and RyR2 were noted between the CAD-SR
and AVD-SR groups (Table 3).
A positive correlation was found between the expression
of L-type Ca2+ channels, RyR2, and SERCA2 (Fig. 2): L-
type Ca2+ channels vs. RyR2 (p = 0.004, r2 = 0.455) and
RyR2 vs. SERCA2 (p = 0.004, r2 = 0.467). L-type Ca2+
channel and SERCA2 expression (p = 0.096, r2 = 0.185)
did not exhibit a robust correlation.
Molecules encoding K+ and Na+ channels
The expression of Kv1.5 was reduced in AF, and
borderline increased expression of HCN2 was observed in
AF; however, the expression of HERG, Kv4.3, and SCN5A
was unchanged (Fig. 1). Atrial samples obtained from
patients in the AVD-SR group showed reduced SERCA2
and Kv1.5 expression compared with the CAD-SR group,
and the MVD-AF group showed decreased RyR2 and
Kv1.5 expression compared with the AVD-SR group
(Table 3).
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Table 2. Primer sequences
Molecule [reference] Primer sequences Annealing temperature, ˚C 
L-type Ca2+ channel [16] F: 5’-CTG GAC AAG AAC CAG CGA CAG TGC G 64
R: 5’-ATC ACG ATC AGG AGG GCC ACA TAG G
RyR2 [9] F: 5’-AAG TGC CAG AGT CAG CAT TC 43 
R: 5’-AGT AGT ATC CAA TGA TGC AG
SERCA2 [9] F: 5’-TTG CAT TGC AGT CTG GAT CA 48
R: 5’-TCC AAA GCA GAG TCA TTA CA 
HERG [16] F: 5’-GTC AAT GCC AAC GAG GAG GT 56 
R: 5’-CTG GTG GAA GCG GAT GAA CT
Kv4.3 [16] F: 5’-CAG CAA GTT CAC AAG CAT CC 52 
R: 5’-AGC TGG CAG GTT AGA ATT GG
Kv1.5 [16] F: 5’-AAC GAG TCC CAG CGC CAG GT 60
R: 5’-AGG CGG ATG ACT CGG AGG AT 
KChIP2 [17] F: 5’-GAG ACC TGG ACG GCT CCT AC 55 
R: 5’-GAC GGA GCC GTC GTG GTT GG
HCN2 [18] F: 5’-CCC GCC TCA TTC GAT ATA TTC AC 57
R: 5’-GAG CGC GAT GGA GTA CTG CTT C 
Na+ channel/SCN5A [16] F: 5’-ATG CAG CTG TGG ACT CCA GG 57 
R: 5’-CAG GCG GAT GAC TCG GAA GA
β-actin F: 5’-GGA CTC CTA TGG TGG GTG ACG AGG 58
R: 5’-GGG AGA GCA TAG CCC TCG TAG AT
L-type Ca2+ channel, voltage-gated L-type Ca2+ channel subunit α1c; RyR2, ryanodine receptor; SERCA2, sarcoplasmic reticular
calcium adenosine triphosphatase; HERG, gene encoding the rapid component of the delayed rectifier IKr; Kv4.3, gene encoding
calcium-independent transient outward current Ito1; Kv1.5, gene encoding the ultrarapid component of the delayed rectifier IKur; KChIP2,
K+ channel-interacting protein 2; HCN2, hyperpolarization-activated cation channel 2 associated with the pacemaker current If; SCN5A,
gene encoding Na+ channel.Oh S, et al. Ion channel and AF    381
Figure 1. Molecular remodeling: mRNA expression levels in
patients with sinus rhythm (SR; blank boxes) and atrial fibrillation
(AF; filled boxes). Error bars indicate the standard deviation. ap <
0.05. L-type Ca2+ channel, voltage-gated L-type Ca2+ channel subunit
α1c; RyR2, ryanodine receptor; SERCA2, sarcoplasmic reticular
calcium adenosine triphosphatase; HERG, gene encoding the rapid
component of the delayed rectifier IKr; Kv4.3, gene encoding calcium-
independent transient outward current Ito1; Kv1.5, gene encoding the
ultrarapid component of the delayed rectifier IKur; KChIP2, K+
channel-interacting protein 2; HCN2, hyperpolarization-activated
cation channel 2 associated with the pacemaker current If; SCN5A,
gene encoding Na+ channel.382 The Korean Journal of Internal Medicine Vol. 25, No. 4, December 2010
Figure 2. Correlations among L-type Ca2+ channel, RyR2, and
SERCA2 expression. L-type Ca2+ channel, voltage-gated L-type
Ca
2+ channel subunit α1c; RyR2, ryanodine receptor; SERCA2,
sarcoplasmic reticular calcium adenosine triphosphatase.
A
C
B
Table 3. mRNA expression levels between the patient groups: coronary artery disease with SR vs. aortic valvular
disease with SR vs. mitral valvular disease with AF
Molecules CAD-SR p valuea AVD-SR p valueb MVD-AF
(n = 7) (n = 5) (n = 5)
L-type Ca2+ channel 0.42 ± 0.08 0.088 0.31 ± 0.11 0.142 0.24 ± 0.05
RyR2 0.80 ± 0.15 0.062 0.63 ± 0.09 0.014 0.38 ± 0.16
SERCA2 0.51 ± 0.09 0.007 0.41 ± 0.03 0.462 0.39 ± 0.04
HERG 0.36 ± 0.08 0.570 0.33 ± 0.11 0.462 0.25 ± 0.15
Kv4.3 0.17 ± 0.12 0.372 0.12 ± 0.08 0.462 0.08 ± 0.07
Kv1.5 0.61 ± 0.07 0.028 0.51 ± 0.04 0.014 0.42 ± 0.01
KChIP2 0.80 ± 0.21 0.570 0.71 ± 0.04 0.014 0.53 ± 0.07
HCN2 0.10 ± 0.04 0.705 0.18 ± 0.14 0.773 0.23 ± 0.06
Na+ channel/SCN5A 0.54 ± 0.14 0.570 0.48 ± 0.17 0.806 0.47 ± 0.05
Values are presented as mean ± SD.
SR, sinus rhythm; AF, atrial fibrillation; CAD, coronary artery disease; AVD, aortic valvular disease; MVD, mitral valvular disease; L-
type Ca
2+ channel, voltage-gated L-type Ca2+ channel subunit α1c; RyR2, ryanodine receptor; SERCA2, sarcoplasmic reticular calcium
adenosine triphosphatase; HERG, gene encoding the rapid component of the delayed rectifier IKr; Kv4.3, gene encoding calcium-
independent transient outward current Ito1; Kv1.5, gene encoding the ultrarapid component of the delayed rectifier IKur; KChIP2, K+
channel-interacting protein 2; HCN2, hyperpolarization-activated cation channel 2 associated with the pacemaker current If; SCN5A,
gene encoding Na
+ channel.
ap value, CAD-SR vs. AVD-SR.
bp value, AVD-SR vs. MVD-AF.KChIP2 expression
The AF group showed significantly reduced KChIP2
expression (Fig. 1). In contrast, the expression of Kv4.3,
which is responsible for Ito, was not decreased in the
patients with AF enrolled in the present study (Fig. 1);
moreover, KChIP2 expression was not correlated with
that of Kv4.3 (p= 0.839, r2= 0.003).
Correlation between molecular remodeling and
structural and functional parameters
Left atrial diameter was negatively correlated with
RyR2 (p = 0.010, r2 = 0.979) and KChIP2 expression (p =
0.018, r2 = 0.965). A correlation between L-type Ca2+
channel expression and left atrial diameter showed
borderline significance (p = 0.090, r2 = 0.828). Left atrial
volume was negatively correlated with KChIP2 expression,
with borderline significance (p = 0.099, r2 = 0.811). Left
ventricular end-systolic diameter (LVESD) was negatively
correlated with RyR2 (p = 0.007, r2 = 0.985), Kv1.5 (p =
0.006, r2 = 0.987), and KChIP2 expression (p = 0.049, r2
= 0.904). Left ventricular end-diastolic diameter
(LVEDD) was negatively correlated with RyR2 (p = 0.014,
r2= 0.973) and Kv1.5 (p= 0.002, r2= 0.997).
FAS of the LA was positively correlated with RyR2 (p =
0.023, r2= 0.954) and KChIP2 expression (p= 0.013, r2=
0.975), and with Kv1.5 expression, with borderline
significance (p = 0.062, r2 = 0.879). FAS of the RA was
positively correlated with RyR2 (p = 0.097, r2 = 0.816)
and Kv1.5 expression (p = 0.052, r2 = 0.899), with
borderline significance. LVEDP was negatively correlated
with HERG expression, with borderline significance (p =
0.069, r2= 0.866).
DISCUSSION
Molecular remodeling
The decreased expression of L-type Ca2+ channels and
SERCA2 found among the patients with AF in this study is
similar to the findings of previous reports [9,19-22].
Decreased expression of RyR2 in AF was observed in this
study; however, this finding is controversial in that
unchanged [9] and decreased [19] expression have been
reported previously. Further investigation is needed to
resolve this issue. Kv4.3 expression has been shown to be
unchanged in AF [8]. Decreased mRNA expression in AF
has been reported [23]; however, that finding is not
compatible with the data produced in this experiment.
Therefore, the expression status of Kv4.3 in AF remains
controversial. Kv1.5 expression was reduced in AF, and
this finding is compatible with findings in a previous
report [4].
AVD versus CAD in patients with SR
L-type Ca2+ channels, RyR2, SERCA2, and Kv1.5 all
showed a tendency toward reduced expression in the
AVD-SR group compared with the CAD-SR group. The
two groups in this study showed no significant differences
in structural and hemodynamic parameters, except for
a higher PASP in the AVD-SR group. Of those molecules,
L-type Ca2+ channel and SERCA2 expression was not
different between the AVD-SR and MVD-AF groups;
however, these groups showed significant differences in
atrium size and FAS. Therefore, the expression status of
L-type Ca2+ channels and SERCA2 might be related to
underlying heart disease. 
KChIP2 expression in AF
The precise meaning and mechanism of these findings
are unclear. Kv4.3 is responsible for most human Ito
current, and KChIP2 could be a physiological regulatory
subunit of Kv4.3 [15]. Therefore, reduced KChIP2 expression
may induce decreased Kv4.3 function. Although the
expression status of Kv4.3 in AF is controversial, the
decreased Ito current observed in AF4 may be related to
decreased KChIP2 expression.
Clinical implications
Molecular remodeling may develop secondary to
changes in the atrial environment, and expression
changes in channel or channel-related molecules known
to affect electrophysiological properties may favor the
initiation and maintenance of atrial tachyarrhythmias,
including AF. Classical therapeutic modalities for AF
target the substrate or rhythm itself; however, recent
progress in our understanding of the remodeling
associated with AF may make “remodeling attenuation
therapy” or “upstream therapy” possible. Some approaches,
including the use of Ca2+ channel blockers, have been
investigated without remarkable results. Remodeling
attenuation therapy using blocking agents should target
the molecules showing increased expression in AF. All of
the molecules evaluated in this study except HCN2
showed reduced expression; therefore, they are not good
therapeutic candidates. HCN2 may also not be a good
candidate because its role in AF is unclear. In this respect,
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substitute for channel blockade as a form of remodeling
attenuation therapy. Recent trials targeting the renin-
angiotensin system have shown positive results for
electrical remodeling [24] and prevention of the
recurrence of AF [25].
Study limitations
We analyzed right appendage tissue in this study;
however, the use of this tissue does not reveal changes
occurring in the rest of the atrium. We cannot know a
molecule’s function based on its mRNA expression alone.
Therefore, additional studies are required to evaluate ion
channel function. In addition, the patient populations
enrolled in this study were heterogeneous. Therefore,
the comparisons made among the groups might have
limitations.
Conclusions
Reduced L-type Ca2+ channel, RyR2, SERCA2, Kv1.5,
and KChIP2 expression and borderline increased HCN2
expression were observed in all patients with AF and
mitral valvular heart disease. RyR2, Kv1.5, and KChIP2
expression was correlated with structural/hemodynamic
parameters. Alterations in ion channel expression and
the anatomical substrate may favor the initiation and
maintenance of AF in patients with mitral valvular heart
disease.
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